[HTML][HTML] Molecular perspectives of SARS-CoV-2: pathology, immune evasion, and therapeutic interventions

M Shah, HG Woo - Molecules and Cells, 2021 - Elsevier
The outbreak of coronavirus disease 2019 (COVID-19) has not only affected human health
but also diverted the focus of research and derailed the world economy over the past year …

The signal pathways and treatment of cytokine storm in COVID-19

L Yang, X Xie, Z Tu, J Fu, D Xu, Y Zhou - Signal transduction and …, 2021 - nature.com
Abstract The Coronavirus Disease 2019 (COVID-19) pandemic has become a global crisis
and is more devastating than any other previous infectious disease. It has affected a …

Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation

I Amigues, AH Pearlman, A Patel, P Reid… - Expert review of …, 2020 - Taylor & Francis
Introduction: The mortality of coronavirus disease 2019 (COVID-19) is frequently driven by
an injurious immune response characterized by the development of acute respiratory …

[HTML][HTML] The development of COVID-19 treatment

Y Yuan, B Jiao, L Qu, D Yang, R Liu - Frontiers in immunology, 2023 - frontiersin.org
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused
a pandemic named coronavirus disease 2019 (COVID-19) that has become the greatest …

[HTML][HTML] Natural immunomodulators treat the cytokine storm in SARS-CoV-2

HS Abbas, MM Abd-Elhakeem… - Advanced …, 2023 - ncbi.nlm.nih.gov
Recently, the world has been dealing with a destructive global pandemic Coronavirus
disease 2019 (COVID-19) infection, since 2020; there were millions of infections and …

A comprehensive updated review on SARS‐CoV‐2 and COVID‐19

YR Ren, A Golding, A Sorbello, P Ji… - The Journal of …, 2020 - Wiley Online Library
This literature review aims to provide a comprehensive current summary of the
pathogenesis, clinical features, disease course, host immune responses, and current …

[HTML][HTML] The role of Interleukin 6 inhibitors in therapy of severe COVID-19

E Nasonov, M Samsonov - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Cytokine storm syndrome (CSS) is a severe complication of inflammatory immune diseases
or treatment of malignancies; it may also appear during the progression of COVID-19. CSS …

SARS‐COV‐2 (COVID‐19): Cellular and biochemical properties and pharmacological insights into new therapeutic developments

H Parlakpinar, M Gunata - Cell Biochemistry and Function, 2021 - Wiley Online Library
COVID‐19 caused by SARS‐COV‐2 first appeared in the Wuhan City of China and began to
spread rapidly among people. Rapid progression of the outbreak has led to a major global …

Advances in immunotherapy for COVID-19: A comprehensive review

M Masoomikarimi, B Garmabi, J Alizadeh… - International …, 2021 - Elsevier
COVID-19 is an acute respiratory syndrome caused by SARS-COV-2 which has now
become a huge pandemic worldwide. The immunopathogenesis of COVID-19 has been …

Exploring the role of immune system and inflammatory cytokines in SARS-CoV-2 induced lung disease: a narrative review

C Tirelli, M De Amici, C Albrici, S Mira, G Nalesso, B Re… - Biology, 2023 - mdpi.com
Simple Summary Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
responsible for the pandemic coronavirus disease-2019 (COVID-19), which can lead to …